We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.
- Authors
Liu, Yanying; Hettinger, Casey L.; Zhang, Dong; Rezvani, Khosrow; Wang, Xuejun; Wang, Hongmin
- Abstract
The ubiquitin proteasome system (UPS) is impaired in Huntington's disease, a devastating neurodegenerative disorder. Sulforaphane, a naturally occurring compound, has been shown to stimulate UPS activity in cell cultures. To test whether sulforaphane enhances UPS function in vivo, we treated UPS function reporter mice ubiquitously expressing the green fluorescence protein (GFP) fused to a constitutive degradation signal that promotes its rapid degradation in the conditions of a healthy UPS. The modified GFP is termed GFP UPS reporter (GFPu). We found that both GFPu and ubiquitinated protein levels were significantly reduced and the three peptidase activities of the proteasome were increased in the brain and peripheral tissues of the mice. Interestingly, sulforaphane treatment also enhanced autophagy activity in the brain and the liver. To further examine whether sulforaphane promotes mutant huntingtin (mHtt) degradation, we treated Huntington's disease cells with sulforaphane and found that sulforaphane not only enhanced mHtt degradation but also reduced mHtt cytotoxicity. Sulforaphane-mediated mHtt degradation was mainly through the UPS pathway as the presence of a proteasome inhibitor abolished this effect. Taken together, these data indicate that sulforaphane activates protein degradation machineries in both the brain and peripheral tissues and may be a therapeutic reagent for Huntington's disease and other intractable disorders.
- Subjects
SULFORAPHANE; HUNTINGTON disease; NEURODEGENERATION; PROTEOLYSIS; UBIQUITIN; PROTEASOME inhibitors; LABORATORY mice
- Publication
Journal of Neurochemistry, 2014, Vol 129, Issue 3, p539
- ISSN
0022-3042
- Publication type
Article
- DOI
10.1111/jnc.12647